BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31679431)

  • 1. Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1.
    Shen DD; Yang ZH; Huang J; Yang F; Lin ZW; Ou YF; Hu MH
    Pharm Biol; 2019 Dec; 57(1):744-752. PubMed ID: 31679431
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD.
    Wang C; Ding H; Tang X; Li Z; Gan L
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28831024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
    Wang TJ; Xie ZH; Zhao ZZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):191-4. PubMed ID: 22574591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Liuweibuqi capsule, a Chinese patent medicine, on the JAK1/STAT3 pathway and MMP9/TIMP1 in a chronic obstructive pulmonary disease rat model.
    Wang C; Li Z; Liu X; Peng Q; Li F; Li D; Wang C
    J Tradit Chin Med; 2015 Feb; 35(1):54-62. PubMed ID: 25842729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on effect of anemoside B4 in improving COPD rats by regulating IL-12/STAT4 and IL-4/STAT6 signaling pathways].
    Wang LL; Chen LY; Ma HM; Xie XX; Luo YY; Shou BY; Yin L
    Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3660-3671. PubMed ID: 34402290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of correlation between pulmonary function and expression levels of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinase-1 among toluene diisocyanate exposed workers].
    Miao PP; Meng T; Jia Q; Niu Y; Ye M; Ji YQ; Ju R; Chen XL; Shao H; Zheng YX; Dai YF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):418-22. PubMed ID: 27141897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Liuweibuqi capsules on CD4
    Wang CY; Ding HZ; Tang X; Li ZG
    J Thorac Dis; 2018 May; 10(5):2700-2711. PubMed ID: 29997932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
    Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
    Beeh KM; Beier J; Kornmann O; Buhl R
    Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of reduced lung function with Th1/Th2 polarization, STAT4/6 expression in rats of chronic obstructive pulmonary disease].
    Wang C; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1233-6. PubMed ID: 24321062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effect on chronic obstructive pulmonary disease of lung
    Zhang Q; Shi Y
    Zhongguo Zhen Jiu; 2020 Sep; 40(9):933-8. PubMed ID: 32959586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of N-acetylcysteine on the cytokines and matrix metalloproteinases in chronic obstructive pulmonary disease rat models].
    Xu L; Cai BQ; Zhu YJ; Guo ZJ; Zhang H; Gu L; Xu XX
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):595-9. PubMed ID: 15355665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Shenqi Bufei Tang on expessions of NF-kappaB, MMP-9 and TIMP-1 in airway remodeling of COPD rat model with lung-Qi deficiency syndrome].
    Zhang K; Zhang Y; Cheng YJ; Lu L
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2129-32. PubMed ID: 19160802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.
    Uysal P; Uzun H
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.
    Zhang Y; Li Y; Ye Z; Ma H
    Med Sci Monit; 2020 Oct; 26():e925278. PubMed ID: 33070147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of invigorating lung and kidney prescription and its components on secretion of cytokines induced by CSE and LPS].
    Wu YS; Chen YL; Li JS; Liu XF; Hao LL; Tian YG; Li Y
    Zhong Yao Cai; 2013 Jun; 36(6):961-6. PubMed ID: 24380286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.